Eliminating hepatitis C in Pakistan could yield a return-on-investment of US$9.10 billion

Pakistan has one of the highest rates of hepatitis C virus (HCV) infection in the world, accounting for over ten percent of global HCV infections. A new modeling study led by the University of Bristol, UK, suggests that achieving the World Health Organization goal of eliminating HCV as a public health problem by 2030 in Pakistan is likely to be highly cost-effective by 2030, cost-saving by 2031, and could deliver US$9.10 billion in savings to the Pakistan national economy by 2050.